GenAI business models in healthcare look different than the digital health revolution of 2009, which was about SaaS and workflow automation.

GenAI business models are about intelligently converting free data into structured fields, making decisions, and taking action, which puts them ahead of older digital health models of simple workflow automation powered by software licensing and SaaS business models. Will that be enough to create winner GenAI companies where the last generation failed?

In this show we'll cover:

Looking at reasons old digital health business models failed
How GenAI is different and why Gen AI companies have advantages compared to incumbents now
Where does Agentic AI fit in?
How AI regulation will shape what's possible in healthcare
How do digital health companies succeed in this challenging environment?

And we'll answer your questions.

Marco Smit is the head of business development at Gesund.ai, which helps AI teams become ready for the FDA. You can follow him on LinkedIn.

Steven Wardell is the Managing Director of Wardell Advisors, a digital health business development consulting firm and the author of The Future of Digital Health. You can follow him at X.com/StevenWardell

DigitalHealth InvestorTalk: Will GenAI Win This Time? With Steven Wardell and Marco Smit